Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19312ExperimentalSmall molecule
Sipoglitazar: Overview.
- Formula / weight
- C25H25N3O4S · 463.55 g/mol (avg)
- Also known as
- 3-(3-ethoxy-1-(4-((2-phenyl-1,3-thiazol-4-yl)methoxy)benzyl)-1h-pyrazol-4-yl)propanoic acid
- Code names
- TAK-654
Resolves to
Clinical / RWD
Structure
InChIKey
SRFCAWATPLCLMG-UHFFFAOYSA-NSMILESCCOC1=NN(CC2=CC=C(OCC3=CSC(=N3)C3=CC=CC=C3)C=C2)C=C1CCC(O)=OTargets
What you can answer from here — as of March 06, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Sipoglitazar, and which of those have an active Phase 3 trial?